<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39372918</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2693-5015</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Sep</Month><Day>16</Day></PubDate></JournalIssue><Title>Research square</Title><ISOAbbreviation>Res Sq</ISOAbbreviation></Journal><ArticleTitle>Antibody responses against influenza A decline with successive years of annual influenza vaccination: results from an Australian Healthcare Worker cohort.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">rs.3.rs-4854923</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.21203/rs.3.rs-4854923/v1</ELocationID><Abstract><AbstractText>Influenza vaccine effectiveness and immunogenicity can be compromised with repeated vaccination. We assessed immunological markers in a cohort of healthcare workers (HCW) from six public hospitals around Australia during 2020-2021. Sera were collected pre-vaccination and ~14 and ~ 180 days post-vaccination and assessed in haemagglutination inhibition assay against egg-grown vaccine and equivalent cell-grown viruses. Responses to vaccination were compared by the number of prior vaccinations. Baseline sera were available for 595 HCW in 2020 and 1031 in 2021. 5% had not been vaccinated during five years prior to enrolment and 55% had been vaccinated every year. Post-vaccination titres for all vaccine antigens were lowest among HCW vaccinated in all 5-prior years and highest among HCW with 0 or 1 prior vaccinations, even after adjustment. This was observed for both influenza A subtypes and was dependent on pre-vaccination titre. Expanded cohorts are needed to better understand how this translates to vaccine effectiveness.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sullivan</LastName><ForeName>Sheena</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0856-0294</Identifier><AffiliationInfo><Affiliation>Monash University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khvorov</LastName><ForeName>Arseniy</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Peter Doherty Insitute for Infection and Immunity.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carolan</LastName><ForeName>Louise</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Peter Doherty Insitute for Infection and Immunity.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dowson</LastName><ForeName>Leslie</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>University of Melbourne.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hadiprodjo</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Melbourne.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sánchez-Ovando</LastName><ForeName>Stephany</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Melbourne.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-2157-8368</Identifier><AffiliationInfo><Affiliation>University of Melbourne.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leung</LastName><ForeName>Vivian</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>University of Melbourne.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hodgson</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>London School of Hygiene and Tropical Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blyth</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Telethon Kids Institute.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Macnish</LastName><ForeName>Marion</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Telethon Kids Institute.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Allen</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Alfred Health and Monash University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hagenauer</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Alfred Health and Monash University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clark</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Queensland Children's Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dougherty</LastName><ForeName>Sonia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Queensland Children's Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Macartney</LastName><ForeName>Kristine</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-4675-0232</Identifier><AffiliationInfo><Affiliation>University of Sydney.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koirala</LastName><ForeName>Archana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>The Children's Hospital at Westmead.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khatami</LastName><ForeName>Ameneh</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9114-6694</Identifier><AffiliationInfo><Affiliation>The Children's Hospital at Westmead.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jadhav</LastName><ForeName>Ajay</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>The Children's Hospital at Westmead.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marshall</LastName><ForeName>Helen</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Adelaide Medical School and Robinson Research Institute.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riley</LastName><ForeName>Kathryn</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Adelaide Medical School and Robinson Research Institute.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wark</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>John Hunter Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delahunty</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Newcastle.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Subbarao</LastName><ForeName>Kanta</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>University of Melbourne.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kucharski</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>London School of Hygiene and Tropical Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fox</LastName><ForeName>Annette</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Peter Doherty Institute for Infection and Immunity.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI141534</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000076942">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Res Sq</MedlineTA><NlmUniqueID>101768035</NlmUniqueID><ISSNLinking>2693-5015</ISSNLinking></MedlineJournalInfo><CoiStatement>Declarations Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: AF, AK, SGS report financial support was provided by National Institutes of Health. AF reports funding/grants from Sanofi Aventis, France. HM reports funding/grants from bioCSL, Pfizer Inc, GlaxoSmithKline. PW reports funding/grants from GlaxoSmithKline Inc, Krystal Biotech, Inc. Vertex Pharmaceuticals, Sanofi. SGS reports consulting for Pfizer Inc, Moderna Inc, Seqirus, Evo Health and Novavax. ACC, CCB are previous Chairs of the Australian Technical Advisory Group on Immunisation (ATAGI). The opinions in this study may not reflect the policy of ATAGI or the Australian Government regarding COVID-19 vaccines.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>12</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>12</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39372918</ArticleId><ArticleId IdType="pmc">PMC11451718</ArticleId><ArticleId IdType="doi">10.21203/rs.3.rs-4854923/v1</ArticleId><ArticleId IdType="pii">rs.3.rs-4854923</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Petrova VN, Russell CA. The evolution of seasonal influenza viruses. Nature Reviews Microbiology. 2018. 2018/01/01;16(1):47–60.</Citation><ArticleIdList><ArticleId IdType="pubmed">29109554</ArticleId></ArticleIdList></Reference><Reference><Citation>Ampofo WK, Azziz-Baumgartner E, Bashir U, Cox NJ, Fasce R, Giovanni M, et al. Strengthening the influenza vaccine virus selection and development process: Report of the 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at WHO headquarters, Geneva, Switzerland, 1–3 April 2014. Vaccine. 2015;33(36):4368–82.</Citation><ArticleIdList><ArticleId IdType="pubmed">26148877</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoskins TW, Davies JR, Smith AJ, Miller CL, Allchin A. Assessment of inactivated influenza-A vaccine after three outbreaks of influenza A at Christ’s Hospital. Lancet. 1979;1(8106):33–5.</Citation><ArticleIdList><ArticleId IdType="pubmed">83475</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones-Gray E, Robinson EJ, Kucharski AJ, Fox A, Sullivan SG. Does repeated influenza vaccination attenuate effectiveness? A systematic review and meta-analysis. Lancet Respir Med. 2023;11(1):27–44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9780123</ArticleId><ArticleId IdType="pubmed">36152673</ArticleId></ArticleIdList></Reference><Reference><Citation>Belongia EA, Skowronski DM, McLean HQ, Chambers C, Sundaram ME, De Serres G. Repeated annual influenza vaccination and vaccine effectiveness: review of evidence. Expert Rev Vaccines. 2017;16(7):1–14.</Citation><ArticleIdList><ArticleId IdType="pubmed">28562111</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramsay LC, Buchan SA, Stirling RG, Cowling BJ, Feng S, Kwong JC, et al. The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis. BMC Med. 2019;17(1):9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6327561</ArticleId><ArticleId IdType="pubmed">30626399</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyer WE, de Bruijn IA, Palache AM, Westendorp RG, Osterhaus AD. Protection against influenza after annually repeated vaccination: a meta-analysis of serologic and field studies. Arch Intern Med. 1999;159(2):182–8.</Citation><ArticleIdList><ArticleId IdType="pubmed">9927102</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson MG, Naleway A, Fry AM, Ball S, Spencer SM, Reynolds S, et al. Effects of Repeated Annual Inactivated Influenza Vaccination among Healthcare Personnel on Serum Hemagglutinin Inhibition Antibody Response to A/Perth/16/2009 (H3N2)-like virus during 2010–11. Vaccine. 2016;34(7):981–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5218812</ArticleId><ArticleId IdType="pubmed">26813801</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung VKY, Aban M, Carolan LA, Laurie KL, Druce J, Slavin MA, et al. Antibody response and influenza-like illness among healthcare workers after influenza vaccination. Public Health Association Australia Communicable Disease Control Conference; 22–24 June; Melbourne, Australia2017.</Citation></Reference><Reference><Citation>Leung VKY, Fox A, Carolan LA, Aban M, Laurie KL, Druce J, et al. Impact of prior vaccination on antibody response and influenza-like illness among Australian healthcare workers after influenza vaccination in 2016. Vaccine. 2021. 2021/05/11/.</Citation><ArticleIdList><ArticleId IdType="pubmed">33985853</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox A, Carolan L, Leung V, Phuong HVM, Khvorov A, Auladell M, et al. Opposing Effects of Prior Infection versus Prior Vaccination on Vaccine Immunogenicity against Influenza A(H3N2) Viruses. Viruses. 2022;14(3).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8949461</ArticleId><ArticleId IdType="pubmed">35336877</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabeshima S, Kashiwagi K, Murata M, Kanamoto Y, Furusyo N, Hayashi J. Antibody response to influenza vaccine in adults vaccinated with identical vaccine strains in consecutive years. J Med Virol. 2007;79(3):320–5.</Citation><ArticleIdList><ArticleId IdType="pubmed">17245715</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedford T, Suchard MA, Lemey P, Dudas G, Gregory V, Hay AJ, et al. Integrating influenza antigenic dynamics with molecular evolution. Elife. 2014;3:e01914.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3909918</ArticleId><ArticleId IdType="pubmed">24497547</ArticleId></ArticleIdList></Reference><Reference><Citation>Skowronski DM, Chambers C, Sabaiduc S, De Serres G, Winter AL, Dickinson JA, et al. A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014–2015 Season. Clin Infect Dis. 2016;63(1):21–32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4901864</ArticleId><ArticleId IdType="pubmed">27025838</ArticleId></ArticleIdList></Reference><Reference><Citation>Cobey S, Hensley SE. Immune history and influenza virus susceptibility. Curr Opin Virol. 2017;22:105–11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5467731</ArticleId><ArticleId IdType="pubmed">28088686</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Vaccines against influenza: WHO position paper - May 2022. Weekly epidemiological record. 2022 13 May 2022;97:185–208.</Citation></Reference><Reference><Citation>Sullivan SG. Preparing for out-of-season influenza epidemics when international travel resumes. Med J Aust. 2022;216(1):25–6.</Citation><ArticleIdList><ArticleId IdType="pubmed">34773924</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng AC, Dwyer DE, Holmes M, Irving L, Simpson G, Senenayake S, et al. Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2019: the Influenza Complications Alert Network (FluCAN). Commun Dis Intell (2018). 2022;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">35469560</ArticleId></ArticleIdList></Reference><Reference><Citation>Fielding JE, Regan AK, Dalton CB, Chilver MB, Sullivan SG. How severe was the 2015 influenza season in Australia? Med J Aust. 2016;204(2):60–1.</Citation><ArticleIdList><ArticleId IdType="pubmed">26821099</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim LL, Bennett NJ, Sullivan SG, Bull AL, Worth LJ. Beyond the COVID-19 pandemic: increasing the uptake of influenza vaccination by health and aged care workers. The Medical journal of Australia. 2022;217(3):157–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9347944</ArticleId><ArticleId IdType="pubmed">35568379</ArticleId></ArticleIdList></Reference><Reference><Citation>HealthTimes. Mandatory flu vaccination for medical staff in NSW. HealthTimes; 2018.  [updated 01-06-2018; cited 2023 27 November]; Available from: https://healthtimes.com.au/hub/immunology/31/news/aap/mandatory-flu-vaccination-for-medical-staff-in-nsw/3391/.</Citation></Reference><Reference><Citation>World Health Organization. Manual for the laboratory diagnosis and virological surveillance of influenza. Geneva: World Health Organization; 2011.</Citation></Reference><Reference><Citation>Zost SJ, Parkhouse K, Gumina ME, Kim K, Diaz Perez S, Wilson PC, et al. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains. Proc Natl Acad Sci U S A. 2017;114(47):12578–83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5703309</ArticleId><ArticleId IdType="pubmed">29109276</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman G, Perera RA, Ngan E, Fang VJ, Cauchemez S, Ip DK, et al. Quantifying homologous and heterologous antibody titre rises after influenza virus infection. Epidemiol Infect. 2016;144(11):2306–16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5530596</ArticleId><ArticleId IdType="pubmed">27018720</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrie JG, Ohmit SE, Johnson E, Cross RT, Monto AS. Efficacy studies of influenza vaccines: effect of end points used and characteristics of vaccine failures. J Infect Dis. 2011;203(9):1309–15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3069734</ArticleId><ArticleId IdType="pubmed">21378375</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranjeva S, Subramanian R, Fang VJ, Leung GM, Ip DKM, Perera R, et al. Age-specific differences in the dynamics of protective immunity to influenza. Nat Commun. 2019;10(1):1660.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6458119</ArticleId><ArticleId IdType="pubmed">30971703</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyer WE, Palache AM, Luchters G, Nauta J, Osterhaus AD. Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination? Virus Res. 2004;103(1–2):125–32.</Citation><ArticleIdList><ArticleId IdType="pubmed">15163500</ArticleId></ArticleIdList></Reference><Reference><Citation>Linderman SL, Chambers BS, Zost SJ, Parkhouse K, Li Y, Herrmann C, et al. Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013–2014 influenza season. Proc Natl Acad Sci U S A. 2014;111(44):15798–803.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4226110</ArticleId><ArticleId IdType="pubmed">25331901</ArticleId></ArticleIdList></Reference><Reference><Citation>Skowronski DM, Chambers C, Sabaiduc S, De Serres G, Winter AL, Dickinson JA, et al. Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015–2016 Season in Canada. J Infect Dis. 2017;216(12):1487–500.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5853508</ArticleId><ArticleId IdType="pubmed">29029166</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoa LNM, Sullivan SG, Mai LQ, Khvorov A, Phuong HVM, Hang NLK, et al. Influenza A(H1N1)pdm09 but not A(H3N2) virus infection induces durable sero-protection: results from the Ha Nam Cohort. J Infect Dis. 2020. Jun 2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9373157</ArticleId><ArticleId IdType="pubmed">32484513</ArticleId></ArticleIdList></Reference><Reference><Citation>Cowling BJ, Lim WW, Perera R, Fang VJ, Leung GM, Peiris JSM, et al. Influenza Hemagglutination-inhibition Antibody Titer as a Mediator of Vaccine-induced Protection for Influenza B. Clin Infect Dis. 2019;68(10):1713–7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6495017</ArticleId><ArticleId IdType="pubmed">30202873</ArticleId></ArticleIdList></Reference><Reference><Citation>Skowronski DM, Janjua NZ, De Serres G, Sabaiduc S, Eshaghi A, Dickinson JA, et al. Low 2012–13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses. PLoS One. 2014;9(3):e92153.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3965421</ArticleId><ArticleId IdType="pubmed">24667168</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>